Bluechiip Limited (ASX:BCT), is pleased to confirm that, further to the ASX Release dated 10 September 2018, the Company has completed the share placement (Placement) of ordinary shares that has raised $5.5 million of funding.

The Company has allotted 93,220,339.00 fully paid ordinary shares at $0.059 (5.9 cents) each to raise a total of $5.5million. After the allotment of the above securities, the Company has 490,253,716 fully paid ordinary shares on issue.

Attached is the Appendix 3B (see link below) in relation to the Placement.

To view the release, please visit:
http://abnnewswire.net/lnk/5PFJ5AEY


About Bluechiip Limited

Bluechiip Limited (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.

Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.

Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.

Bluechiip: Delivering confidence in every sample.

    

Contact

Corporate enquiries
Andrew McLellan
Managing Director - CEO
Ph: +61-457-823-470
andrew.mclellan@bluechiip.com

Media
Richard Allen
Ph: +61-3-9915-6341
Oxygen Financial PR
richard@oxygenpr.com.au



Link: App 3B - Completion of Placement


Related Companies

Bluechiip Limited
             


Related Industry Topics: